Literature DB >> 18164589

Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK.

Joost J F P Luiken1, Didier Vertommen, Susan L M Coort, Daphna D J Habets, Mohammed El Hasnaoui, Maurice M L Pelsers, Benoit Viollet, Arend Bonen, Louis Hue, Mark H Rider, Jan F C Glatz.   

Abstract

Contraction-induced glucose uptake is only partly mediated by AMPK activation. We examined whether the diacylglycerol-sensitive protein kinase D (PKD; also known as novel PKC isoform mu) is also involved in the regulation of glucose uptake in the contracting heart. As an experimental model, we used suspensions of cardiac myocytes, which were electrically stimulated to contract or treated with the contraction-mimicking agent oligomycin. Induction of contraction at 4 Hz in cardiac myocytes or treatment with 1 microM oligomycin enhanced (i) autophosphorylation of PKD at Ser916 by 5.1- and 3.8-fold, respectively, (ii) phosphorylation of PKD's downstream target cardiac-troponin-I (cTnI) by 2.9- and 2.1-fold, respectively, and (iii) enzymatic activity of immunoprecipitated PKD towards the substrate peptide syntide-2 each by 1.5-fold. Although AMPK was also activated under these same conditions, in vitro phosphorylation assays and studies with cardiac myocytes from AMPKalpha2(-/-) mice indicated that activation of PKD occurs independent of AMPK activation. CaMKKbeta, and the cardiac-specific PKC isoforms alpha, delta, and epsilon were excluded as upstream kinases for PKD in contraction signaling because none of these kinases were activated by oligomycin. Stimulation of glucose uptake and induction of GLUT4 translocation in cardiac myocytes by contraction and oligomycin each were sensitive to inhibition by the PKC/PKD inhibitors staurosporin and calphostin-C. Together, these data elude to a role of PKD in contraction-induced GLUT4 translocation. Finally, the combined actions of PKD on cTnI phosphorylation and on GLUT4 translocation would efficiently link accelerated contraction mechanics to increased energy production when the heart is forced to increase its contractile activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164589     DOI: 10.1016/j.cellsig.2007.11.007

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  14 in total

1.  Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction.

Authors:  Mariah H Goodall; Robert D Wardlow; Rebecca R Goldblum; Andrew Ziman; W Jonathan Lederer; William Randall; Terry B Rogers
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 2.  Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins.

Authors:  R John Solaro
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

3.  Exercise-induced histone modifications in human skeletal muscle.

Authors:  Sean L McGee; Erin Fairlie; Andrew P Garnham; Mark Hargreaves
Journal:  J Physiol       Date:  2009-12-15       Impact factor: 5.182

4.  Overexpression of vesicle-associated membrane protein (VAMP) 3, but not VAMP2, protects glucose transporter (GLUT) 4 protein translocation in an in vitro model of cardiac insulin resistance.

Authors:  Robert W Schwenk; Yeliz Angin; Laura K M Steinbusch; Ellen Dirkx; Nicole Hoebers; Will A Coumans; Arend Bonen; Jos L V Broers; Guillaume J J M van Eys; Jan F C Glatz; Joost J F P Luiken
Journal:  J Biol Chem       Date:  2012-08-30       Impact factor: 5.157

Review 5.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

6.  Chronic AICAR treatment prevents metabolic changes in cardiomyocytes exposed to free fatty acids.

Authors:  Christelle Viglino; Bernard Foglia; Christophe Montessuit
Journal:  Pflugers Arch       Date:  2019-05-31       Impact factor: 3.657

7.  Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes.

Authors:  Ellen Dirkx; Robert W Schwenk; Will A Coumans; Nicole Hoebers; Yeliz Angin; Benoit Viollet; Arend Bonen; Guillaume J J M van Eys; Jan F C Glatz; Joost J F P Luiken
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

8.  AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.

Authors:  Nicolas Dzamko; Jonathan D Schertzer; James G Ryall; Rohan Steel; S Lance Macaulay; Sheena Wee; Zhi-Ping Chen; Belinda J Michell; Jonathan S Oakhill; Matthew J Watt; Sebastian Beck Jørgensen; Gordon S Lynch; Bruce E Kemp; Gregory R Steinberg
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

Review 9.  Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes.

Authors:  Laura K M Steinbusch; Robert W Schwenk; D Margriet Ouwens; Michaela Diamant; Jan F C Glatz; Joost J F P Luiken
Journal:  Cell Mol Life Sci       Date:  2011-05-06       Impact factor: 9.261

10.  Cleavage of protein kinase D after acute hypoinsulinemia prevents excessive lipoprotein lipase-mediated cardiac triglyceride accumulation.

Authors:  Min Suk Kim; Fang Wang; Prasanth Puthanveetil; Girish Kewalramani; Sheila Innis; Lucy Marzban; Susan F Steinberg; Travis D Webber; Timothy J Kieffer; Ashraf Abrahani; Brian Rodrigues
Journal:  Diabetes       Date:  2009-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.